GET THE APP

欧州臨床腫瘍学ジャーナル

ISSN - 2732-2654

音量 6, 問題 1 (2024)

視点

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

視点

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

視点

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

視点

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

視点

Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy

Albert Kevin

視点

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

視点

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

視点

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

視点

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

視点

Therapeutic Agents Targeting Gene Expression Modifications, Epigenetic Drugs Show Promise in Treating Diseases Like Cancer and Neurological Disorders, Crucial for Precision Medicine Advancements

Allen Robert

リサーチ

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

リサーチ

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

リサーチ

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

リサーチ

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

リサーチ

Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations

Reza Bozorgpour

研究論文

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

研究論文

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

研究論文

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

研究論文

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

研究論文

The Importance of Fourier-Transformed Infrared Spectroscopy (FT-IR) In The Diagnosis of Stomach Cancer

Yilmaz Sahin, Mevlut Albayrak

短いコミュニケーション

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

短いコミュニケーション

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

短いコミュニケーション

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

短いコミュニケーション

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi

短いコミュニケーション

The Introduction of Nivolumab Plus Ipilimumab in the Treatment of aRCC Patients: Differences Between Low- and High-Volume Centers in Germany

Marcus Derigs, Günter Niegisch, Tobias R. Richter, Benedikt Mönig, Rene Mage, Axel Hegele, Thomas Steiner, Viktor Grünwald and Philipp Ivanyi